We’re proud to be a sponsoring partner of EUSAAT 2019 Meet our team We’d love to chat: Oral Presentations: Development, pre-validation and validation of the EpiDerm in vitro skin irritation protocol for the medical devices… Read More
Ashland, MA – A special open-access issue of Toxicology In Vitro, Reconstructed human epidermis (RhE) model for evaluation of medical devices irritant capacity, includes five papers that feature MatTek’s industry-leading EpiDerm tissue. The papers focus on pre-validation and validation of… Read More
MatTek is pleased to announce that its wholly-owned subsidiary, MatTek In Vitro Life Science Laboratories (IVLSL), has begun production of its industry-leading EpiIntestinal tissue in Bratislava, Slovakia. “We have an established tradition of producing identical, reproducible tissues no matter the… Read More
See MatTek at World Preclinical Congress 2017 in Boston, MA MatTek is pleased to announce its attendance at the 16th Annual World Preclinical Congress, June 12 through June 16, 2017, in Boston, MA. World Preclinical Congress is an essential scientific… Read More
MatTek IVLSL will lead a presentation at CAAT Academy in Brussels, Belgium. The course, In Vitro Skin & Eye Models – Part 1, will focus on OECD guidelines for local toxicity testing. The presentation will demonstrate MatTek’s EpiOcular product’s applicability for… Read More
